Vasconcelos Claudia Cristina Ferreira, Aurenção Juliana Calvet Kallenbach, Thuler Luiz Claudio Santos, Camargo Solange, Alvarenga Marcos Papais, Alvarenga Regina Maria Papais
Universidade Federal do Estado do Rio de Janeiro, Rua Mariz e Barros 775, Departamento de Neurologia, Tijuca, Rio de Janeiro CEP: 20270-901, Brazil.
Universidade Federal do Estado do Rio de Janeiro and Instituto Nacional de Câncer, Rua André Cavalcanti, 37 - Centro, Rio de Janeiro, RJ CEP 20231050, Brazil.
Mult Scler Relat Disord. 2016 Jul;8:27-34. doi: 10.1016/j.msard.2016.03.011. Epub 2016 Mar 30.
Predicting the long-term prognosis of patients with multiple sclerosis (MS) remains an uncertain and difficult task, with most data having been obtained exclusively from Caucasian cohorts.
To investigate clinical prognostic factors in a Brazilian mixed-race cohort.
Demographic, clinical and therapeutic factors were investigated in 303 patients with relapsing-remitting MS in relation to the following outcomes: time until reaching Expanded Disability Status Scale (EDSS) 3 and EDSS 6, and until secondary progression.
Benign course was significantly more frequent among Caucasians when compared to Afrodescendants. Patients with a malignant course had more than one relapse in the first year of the disease and reached EDSS 3 faster if treatment was not started. In the multivariate analysis, the following factors were associated with a significantly shorter time until the established outcomes: male gender, being of African descent, non-recovery after the first relapse, two or more relapses during the first year, a short interval between initial relapses, initial polysymptomatic presentation of pyramidal and cerebellar dysfunction and no treatment prior to reaching EDSS 3.
Being of African descent was found to be an unfavorable factor for all outcomes, reinforcing the need to take ethnicity into consideration when defining treatment, particularly in mixed MS populations.
预测多发性硬化症(MS)患者的长期预后仍然是一项不确定且困难的任务,大多数数据仅来自白种人队列。
研究巴西混血人种队列中的临床预后因素。
对303例复发缓解型MS患者的人口统计学、临床和治疗因素进行调查,涉及以下结局:达到扩展残疾状态量表(EDSS)3级和6级的时间,以及继发进展的时间。
与非洲裔后代相比,白种人良性病程更为常见。恶性病程的患者在疾病第一年复发不止一次,若未开始治疗则更快达到EDSS 3级。在多变量分析中,以下因素与达到既定结局的时间显著缩短相关:男性、非洲裔、首次复发后未恢复、第一年复发两次或更多次、初次复发间隔时间短、初次出现锥体和小脑功能障碍多症状表现以及在达到EDSS 3级之前未接受治疗。
发现非洲裔是所有结局的不利因素,这强化了在确定治疗方案时考虑种族因素的必要性,尤其是在混合性MS人群中。